DK4452260T3 - Gap-junction-modulatorer og deres anvendelse til behandling af aldersrelateret makuladegeneration - Google Patents
Gap-junction-modulatorer og deres anvendelse til behandling af aldersrelateret makuladegenerationInfo
- Publication number
- DK4452260T3 DK4452260T3 DK22843707.5T DK22843707T DK4452260T3 DK 4452260 T3 DK4452260 T3 DK 4452260T3 DK 22843707 T DK22843707 T DK 22843707T DK 4452260 T3 DK4452260 T3 DK 4452260T3
- Authority
- DK
- Denmark
- Prior art keywords
- maculate
- degeneration
- age
- gap
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4452260T3 true DK4452260T3 (da) | 2026-03-30 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22843707.5T DK4452260T3 (da) | 2021-12-22 | 2022-12-21 | Gap-junction-modulatorer og deres anvendelse til behandling af aldersrelateret makuladegeneration |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118366A1 (en) | 2023-06-29 |
| CA3240515A1 (en) | 2023-06-29 |
| US20250018002A1 (en) | 2025-01-16 |
| EP4452260B1 (en) | 2026-01-28 |
| EP4452260A1 (en) | 2024-10-30 |
| JP2025500123A (ja) | 2025-01-09 |
| IL313729A (en) | 2024-08-01 |
| FI4452260T3 (fi) | 2026-03-30 |
| CN118450892A (zh) | 2024-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3678668T3 (da) | ENPP1-inhibitorer og deres anvendelse til behandling af kræft | |
| DK3579848T3 (da) | Multispecifikke bindende proteiner til aktivering af naturlige dræberceller og terapeutiske anvendelser heraf til behandling af kræft | |
| IL281683A (en) | Dll3 binding proteins and methods of use | |
| DK3694529T3 (da) | Trispecifikke proteiner og anvendelsesfremgangsmåder | |
| EP4424364C0 (en) | COMBINATIONS FOR USE IN THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS | |
| DK3609514T3 (da) | Grupper af levende bakterier og deres anvendelse ved behandlingen af mikrobiom-dysbiose | |
| DK3849534T3 (da) | Kombination af dasatinib og adagrasib til anvendelse i behandling af ikke-småcellet lungecancer | |
| DK4014976T3 (da) | Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan | |
| DK3830119T3 (da) | Anti-btn3a-antistoffer og deres anvendelse til behandling af kræft eller infektionssygdomme | |
| EP3681862C0 (en) | BETA-HYDROXY HETEROCYCLIC AMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCEMIA | |
| EP3565812A4 (en) | TUBULIN BINDING COMPOUNDS AND THEIR THERAPEUTIC USE | |
| DK3983064T3 (da) | COT-modulatorer og fremgangsmåder til anvendelse deraf | |
| DK3668972T3 (da) | Konstruerede dnase-enzymer og anvendelse i terapi | |
| DK3790879T3 (da) | Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft | |
| DK3443000T3 (da) | Cd80-varianter af immunmodulerende proteiner og deres anvendelse | |
| IL273177B (en) | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | |
| DK3861985T3 (da) | Sammensætninger og fremgangsmåder til behandling af øjensygdomme | |
| EP3523338C0 (en) | TRIBLOCK PREPOLYMERS AND THEIR USE IN SILICONE HYDROGELS | |
| DK3565579T3 (da) | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| EP3996746A4 (en) | T-TYPE CALCIUM CHANNEL MODULATOR FORMULATIONS AND METHODS OF USE THEREOF | |
| EP3870203A4 (en) | Therapeutic combinations of tdfrps and additional agents and methods of use | |
| DK3723739T3 (da) | Isoxazolin-parasiticidformuleringer og deres anvendelse til behandling af blepharitis | |
| DK3431507T5 (da) | Fusionsprotein omfattende nervevækstfaktor og fremstillingsfremgangsmåde og anvendelse deraf | |
| DK3853218T3 (da) | Somatostatinmodulatorer og anvendelser deraf | |
| DK3722291T3 (da) | Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme |